INSIG1 and neoplasm: IHC analyses and Oil Red O staining of tumor tissues revealed that semaglutide administration decreased high‐fat diet‐increased lipid levels (Figure 5d) and Ki67 expression in tumor tissues (Figure 5e), and this reduction was further promoted by combined treatment with the Insig1/2 loop 1 peptide.